A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop

Kwon Bae, Byung Ho Lee, Hyun Yong Hwang, Seok Hoon Jeong, Seong Geun Hong, Chulhun L. Chang, Hyo Sun Kwak, Hyoung Jin Kim, Hasik Youn

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objectives: To characterize a novel ceftazidime-hydrolysing CTX-M mutant, designated CTX-M-54, produced by Klebsiella pneumoniae clinical isolate BDK0419 and to investigate its genetic environment. Methods: Antimicrobial susceptibilities were determined by disc diffusion and agar dilution methods, and the double-disc synergy test was carried out. Detection of genes encoding class A β-lactamases was performed by PCR amplification, and the genetic organization of the blaCTX-M-54 gene was investigated by PCR and sequencing of the regions surrounding this gene. Kinetic parameters were determined from purified CTX-M-54. Results: The strain BDK0419 contained a transferable plasmid with a molecular size of ∼21 kbp that carries both blaSHV-2a and blaCTX-M-54 β-lactamase genes, along with two other plasmids. The blaCTX-M-54 gene was flanked upstream by an IS Ecp1 insertion sequence and downstream by an IS 903-like element. CTX-M-54 had a P167Q substitution within the omega loop region of class A β-lactamases compared with the sequence of CTX-M-3. The MIC of ceftazidime for K. pneumoniae BDK0419 was 16-fold higher than that of cefotaxime; however, the kinetic parameter of CTX-M-54 against ceftazidime revealed a low catalytic efficiency. Conclusions: This work shows once again that novel CTX-M enzymes with an expanded activity towards ceftazidime through a single amino acid substitution can be identified from clinical isolates. Thus, detection of CTX-M enzymes can no longer be based solely on the resistance phenotypes of clinical isolates towards ceftazidime and cefotaxime.

Original languageEnglish
Pages (from-to)315-319
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Volume58
Issue number2
DOIs
Publication statusPublished - 2006 Aug 1

Fingerprint

Ceftazidime
Amino Acid Substitution
Cefotaxime
Genes
Klebsiella pneumoniae
Plasmids
Polymerase Chain Reaction
Insertional Mutagenesis
Enzymes
Agar
Phenotype

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Bae, Kwon ; Lee, Byung Ho ; Hwang, Hyun Yong ; Jeong, Seok Hoon ; Hong, Seong Geun ; Chang, Chulhun L. ; Kwak, Hyo Sun ; Kim, Hyoung Jin ; Youn, Hasik. / A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop. In: Journal of Antimicrobial Chemotherapy. 2006 ; Vol. 58, No. 2. pp. 315-319.
@article{6ce0c4b25db94b7bbf745626f71d397e,
title = "A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop",
abstract = "Objectives: To characterize a novel ceftazidime-hydrolysing CTX-M mutant, designated CTX-M-54, produced by Klebsiella pneumoniae clinical isolate BDK0419 and to investigate its genetic environment. Methods: Antimicrobial susceptibilities were determined by disc diffusion and agar dilution methods, and the double-disc synergy test was carried out. Detection of genes encoding class A β-lactamases was performed by PCR amplification, and the genetic organization of the blaCTX-M-54 gene was investigated by PCR and sequencing of the regions surrounding this gene. Kinetic parameters were determined from purified CTX-M-54. Results: The strain BDK0419 contained a transferable plasmid with a molecular size of ∼21 kbp that carries both blaSHV-2a and blaCTX-M-54 β-lactamase genes, along with two other plasmids. The blaCTX-M-54 gene was flanked upstream by an IS Ecp1 insertion sequence and downstream by an IS 903-like element. CTX-M-54 had a P167Q substitution within the omega loop region of class A β-lactamases compared with the sequence of CTX-M-3. The MIC of ceftazidime for K. pneumoniae BDK0419 was 16-fold higher than that of cefotaxime; however, the kinetic parameter of CTX-M-54 against ceftazidime revealed a low catalytic efficiency. Conclusions: This work shows once again that novel CTX-M enzymes with an expanded activity towards ceftazidime through a single amino acid substitution can be identified from clinical isolates. Thus, detection of CTX-M enzymes can no longer be based solely on the resistance phenotypes of clinical isolates towards ceftazidime and cefotaxime.",
author = "Kwon Bae and Lee, {Byung Ho} and Hwang, {Hyun Yong} and Jeong, {Seok Hoon} and Hong, {Seong Geun} and Chang, {Chulhun L.} and Kwak, {Hyo Sun} and Kim, {Hyoung Jin} and Hasik Youn",
year = "2006",
month = "8",
day = "1",
doi = "10.1093/jac/dkl252",
language = "English",
volume = "58",
pages = "315--319",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "2",

}

A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop. / Bae, Kwon; Lee, Byung Ho; Hwang, Hyun Yong; Jeong, Seok Hoon; Hong, Seong Geun; Chang, Chulhun L.; Kwak, Hyo Sun; Kim, Hyoung Jin; Youn, Hasik.

In: Journal of Antimicrobial Chemotherapy, Vol. 58, No. 2, 01.08.2006, p. 315-319.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop

AU - Bae, Kwon

AU - Lee, Byung Ho

AU - Hwang, Hyun Yong

AU - Jeong, Seok Hoon

AU - Hong, Seong Geun

AU - Chang, Chulhun L.

AU - Kwak, Hyo Sun

AU - Kim, Hyoung Jin

AU - Youn, Hasik

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Objectives: To characterize a novel ceftazidime-hydrolysing CTX-M mutant, designated CTX-M-54, produced by Klebsiella pneumoniae clinical isolate BDK0419 and to investigate its genetic environment. Methods: Antimicrobial susceptibilities were determined by disc diffusion and agar dilution methods, and the double-disc synergy test was carried out. Detection of genes encoding class A β-lactamases was performed by PCR amplification, and the genetic organization of the blaCTX-M-54 gene was investigated by PCR and sequencing of the regions surrounding this gene. Kinetic parameters were determined from purified CTX-M-54. Results: The strain BDK0419 contained a transferable plasmid with a molecular size of ∼21 kbp that carries both blaSHV-2a and blaCTX-M-54 β-lactamase genes, along with two other plasmids. The blaCTX-M-54 gene was flanked upstream by an IS Ecp1 insertion sequence and downstream by an IS 903-like element. CTX-M-54 had a P167Q substitution within the omega loop region of class A β-lactamases compared with the sequence of CTX-M-3. The MIC of ceftazidime for K. pneumoniae BDK0419 was 16-fold higher than that of cefotaxime; however, the kinetic parameter of CTX-M-54 against ceftazidime revealed a low catalytic efficiency. Conclusions: This work shows once again that novel CTX-M enzymes with an expanded activity towards ceftazidime through a single amino acid substitution can be identified from clinical isolates. Thus, detection of CTX-M enzymes can no longer be based solely on the resistance phenotypes of clinical isolates towards ceftazidime and cefotaxime.

AB - Objectives: To characterize a novel ceftazidime-hydrolysing CTX-M mutant, designated CTX-M-54, produced by Klebsiella pneumoniae clinical isolate BDK0419 and to investigate its genetic environment. Methods: Antimicrobial susceptibilities were determined by disc diffusion and agar dilution methods, and the double-disc synergy test was carried out. Detection of genes encoding class A β-lactamases was performed by PCR amplification, and the genetic organization of the blaCTX-M-54 gene was investigated by PCR and sequencing of the regions surrounding this gene. Kinetic parameters were determined from purified CTX-M-54. Results: The strain BDK0419 contained a transferable plasmid with a molecular size of ∼21 kbp that carries both blaSHV-2a and blaCTX-M-54 β-lactamase genes, along with two other plasmids. The blaCTX-M-54 gene was flanked upstream by an IS Ecp1 insertion sequence and downstream by an IS 903-like element. CTX-M-54 had a P167Q substitution within the omega loop region of class A β-lactamases compared with the sequence of CTX-M-3. The MIC of ceftazidime for K. pneumoniae BDK0419 was 16-fold higher than that of cefotaxime; however, the kinetic parameter of CTX-M-54 against ceftazidime revealed a low catalytic efficiency. Conclusions: This work shows once again that novel CTX-M enzymes with an expanded activity towards ceftazidime through a single amino acid substitution can be identified from clinical isolates. Thus, detection of CTX-M enzymes can no longer be based solely on the resistance phenotypes of clinical isolates towards ceftazidime and cefotaxime.

UR - http://www.scopus.com/inward/record.url?scp=33748063296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748063296&partnerID=8YFLogxK

U2 - 10.1093/jac/dkl252

DO - 10.1093/jac/dkl252

M3 - Article

C2 - 16785225

AN - SCOPUS:33748063296

VL - 58

SP - 315

EP - 319

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 2

ER -